137 related articles for article (PubMed ID: 35393747)
1. Development of Fluorophosphoramidate as a Biocompatibly Transformable Functional Group and its Application as a Phosphate Prodrug for Nucleoside Analogs.
Yoshida Y; Zheng T; Tanabe W; Tomoike F; Hashiya F; Suzuki T; Hirota S; Saiki Y; Horii A; Hirayama A; Soga T; Kimura Y; Abe H
ChemMedChem; 2022 Sep; 17(17):e202200188. PubMed ID: 35393747
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine.
Zhang L; Qi K; Xu J; Xing Y; Wang X; Tong L; He Z; Xu W; Li X; Jiang Y
J Med Chem; 2023 Mar; 66(6):4150-4166. PubMed ID: 36867101
[TBL] [Abstract][Full Text] [Related]
3. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
Sinokrot H; Smerat T; Najjar A; Karaman R
Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
[No Abstract] [Full Text] [Related]
4. Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules.
Meier C; Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):282-92. PubMed ID: 16735066
[TBL] [Abstract][Full Text] [Related]
5. An overview of ProTide technology and its implications to drug discovery.
Serpi M; Pertusati F
Expert Opin Drug Discov; 2021 Oct; 16(10):1149-1161. PubMed ID: 33985395
[No Abstract] [Full Text] [Related]
6. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.
Slusarczyk M; Serpi M; Pertusati F
Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
Thornton PJ; Kadri H; Miccoli A; Mehellou Y
J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
[TBL] [Abstract][Full Text] [Related]
8. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?
Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
[TBL] [Abstract][Full Text] [Related]
10. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE
Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
[TBL] [Abstract][Full Text] [Related]
12. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
Zhao C; Jia X; Schols D; Balzarini J; Meier C
ChemMedChem; 2021 Feb; 16(3):499-512. PubMed ID: 33089929
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?
Meier C
Antivir Chem Chemother; 2017 Dec; 25(3):69-82. PubMed ID: 29096525
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside Phosphate-Conjugates Come of Age: Catalytic Transformation, Polymerase Recognition and Antiviral Properties.
Groaz E; Herdewijn P
Curr Med Chem; 2015; 22(34):3980-90. PubMed ID: 26597062
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antiviral Activity of a Series of 2'-
Dentmon ZW; Kaiser TM; Liotta DC
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171951
[TBL] [Abstract][Full Text] [Related]
17. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
18. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy.
De Clercq E; Field HJ
Br J Pharmacol; 2006 Jan; 147(1):1-11. PubMed ID: 16284630
[TBL] [Abstract][Full Text] [Related]
19. Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy.
Li J; Liu S; Shi J; Wang X; Xue Y; Zhu HJ
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):870-887. PubMed ID: 33855276
[TBL] [Abstract][Full Text] [Related]
20. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.
McGuigan C; Cahard D; Sheeka HM; De Clercq E; Balzarini J
J Med Chem; 1996 Apr; 39(8):1748-53. PubMed ID: 8648614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
